Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Fire needle therapy's benefits and safety for alopecia areata need more evidence.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Acupuncture and moxibustion may help treat hair loss, but more research is needed.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

Lasers and light therapies are effective in promoting hair regrowth for different types of hair loss.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Korean medicine may help with hair growth in alopecia, but more research is needed to confirm this.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Oral alitretinoin can quickly regrow hair in alopecia universalis.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Tofacitinib is an effective and safe treatment for alopecia areata.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.